Novel approach blocks amyloid production in Alzheimer’s mouse model

Offering a potential early intervention for Alzheimer’s disease (AD), researchers have identified compounds that block the production of beta amyloid peptides in mice. The build-up of beta amyloid plaques is widely believed to cause irreversible brain damage, resulting in a host of cognitive and motor impairments broadly associated with AD, which accounts for about 60 to 80 percent of all cases of dementia in the United States. —> Read More